No headlines found.
Bone Biologics Expands Trial Sites
Globe Newswire (Tue, 8-Sep 8:30 AM ET)
Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Globe Newswire (Thu, 3-Sep 8:30 AM ET)
Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1
Globe Newswire (Wed, 12-Aug 8:00 AM ET)
Bone Biologics - Warrants trades on the stock market under the symbol BBLGW.
As of November 5, 2026, BBLGW stock price was flat at $7.01 with million shares trading.
BBLGW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, BBLGW traded as high as $200.64 and as low as $.70.
BBLGW has underperformed the market in the last year with a return of -41.1%, while the SPY ETF gained +9.7%. In the last 3 month period, BBLGW fell short of the market, returning -12.4%, while SPY returned -4.7%. However, in the most recent 2 weeks BBLGW has outperformed the stock market by returning 0.0%, while SPY returned -5.2%.
BBLGW support price is $5.86 and resistance is $8.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BBLGW shares will trade within this expected range on the day.
